您的位置: 首页 > 农业专利 > 详情页

USE OF (2-IMIDAZOLIN-2-YL-AMINO) QUINOXALINES FOR THE TREATMENT OF EYEGEN INJURY
专利权人:
Inc.; 92612;Allergan; Irvine; US; Calif.
发明人:
WHEELER, Larry A., Irvine, CA 92715, US,WOLDEMUSSIE, Elizabeth, Laguna Niguel, CA 92677, US,LAI, Ronald K., Santa Ana, CA 92704, US
申请号:
DE69636012
公开号:
DE000069636012T3
申请日:
1996.06.17
申请国别(地区):
DE
年份:
2012
代理人:
摘要:
A method according to which neuroprotection is conferred upon ocular nerve cells by administration of a drug of formula (I) to the optic nerve and/or retina of a mammal within a period prior to or following an insult to ocular nerve cells but prior to cell death, wherein the 2-imidazolin-2-ylamino group may be in either the 5- or 6-position of the quinoxaline nucleus; x, y and z may be in any of the remaining 5-, 6-, 7- or 8-positions and are selected from hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl; and R is an optional substituent in either the 2-or 3-position of the quinoxaline nucleus and may be hydrogen, lower alkyl or lower alkoxy is disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充